Alvarez-Demalde Francisco 4

What Happened

• Francisco Alvarez‑Demalde, a director of VTEX (NYSE: VTEX), reported derivative-related transactions on July 1, 2026. The filing shows conversion of derivative securities (RSUs) into 2,029 shares (972 + 1,057) and the acquisition/recording of two RSU awards of 31,439 shares each (totaling 62,878 RSUs). All transactions are reported at $0 per share, reflecting awards/settlements rather than open‑market trades.
• The filings include both conversion (code C) and other acquisition (code J) entries; footnotes indicate these are Restricted Stock Units (RSUs) and include new grants dated July 1, 2026. A separate footnote also references stock options granted on July 1, 2026 with a standard vesting schedule.

Key Details

• Transaction date: July 1, 2026. Reported prices: $0.00 per share (award/settlement), with conversion entries showing $0 as well.
• Share counts reported: conversions of 972 and 1,057 shares (total 2,029) and two acquisitions of 31,439 RSUs each (total 62,878 RSUs).
• Shares owned after transaction: not specified in the provided excerpt.
• Vesting/award notes: RSUs vest in tranches (8.33% initial tranche on listed dates, then 8.33% every three months per footnotes F3–F5). Stock options granted on July 1, 2026 vest similarly (F6).
• Holds/beneficial ownership: the securities tied to some entries are held for the benefit of Riverwood Capital GP II Ltd. and affiliates; Mr. Alvarez‑Demalde disclaims beneficial ownership except to the extent of any pecuniary interest (F2).
• Timing/filing: no late filing flag shown. As a foreign private issuer, VTEX’s insiders are exempt from Sections 16(b) and 16(c) of the Exchange Act (remark).

Context

• These entries reflect awards and RSU settlements (derivative conversions), not open‑market purchases or sales — transactions at $0 indicate grant/settlement rather than cash transactions.
• Because the reported securities are held for Riverwood and the reporting person disclaims beneficial ownership, this filing may reflect institutional holdings/administration rather than personal trading by the director.
• Awards and option grants commonly follow company compensation plans and do not by themselves imply a bullish or bearish view; they are part of long‑term compensation and subject to vesting schedules.